Program
Beclomethasone
Also written as “Beclomethasone dipropionate”, “Beclometasone/Formoterol/Glycopyrrolate” and “beclomethasone”.
Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic, Perennial · Graft vs Host Disease, led by 7 companies.
Drug pageBeclomethasone: every studyMany companies study it; this page follows only the 44 they lead. All 85 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Chiesi Farmaceuticiits history only | 220 open or running | phase 4since Oct 28, 2020 | Sep 29, 2006 | none ahead |
| Teva Pharmaceutical Industries | 140 open or running | phase 4since Oct 28, 2003 | Oct 28, 2003 | none ahead |
| Soligenixits history only | 30 open or running | phase 3since Jun 19, 2009 | Jun 19, 2009 | none ahead |
| Adamis Pharmaceuticalsits history only | 20 open or running | phase 3since Feb 6, 2019 | Feb 6, 2019 | none ahead |
| Enteron Pharmaceuticalsits history only | 10 open or running | phase 3since Oct 4, 2005 | Oct 4, 2005 | none ahead |
| Lunan Pharmaceutical Groupits history only | 11 open or running | phase 3since Jul 21, 2026 | Jul 21, 2026 | Jun 2028phase 3 · NCT07768891 |
| SOFARits history only | 10 open or running | phase 1since Apr 26, 2021 | Apr 26, 2021 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Teva Pharmaceutical Industries only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 28, 2003First study: phase 4 study in AsthmaFirst studyNCT00071552 · 49 enrolled · United States
- Oct 8, 2004Phase 3 study in AsthmaNCT00094016 · 440 enrolled · United States, Puerto Rico
- May 2, 2005Phase 3 study in AsthmaNCT00109668 · 415 enrolled · United States, Puerto Rico
- Nov 4, 2005Phase 4 study in AsthmaNCT00250341 · 34 enrolled · United States
- Mar 2, 2009Phase 2 study in Rhinitis, Allergic, SeasonalNCT00854360 · 487 enrolled · United States
- Sep 30, 2009Phase 3 study in Rhinitis, Allergic, PerennialNCT00988247 · 529 enrolled · United States
- Dec 2, 2009Phase 3 study in Rhinitis, Allergic, SeasonalNCT01024608 · 340 enrolled · United States
- May 27, 20102 phase 3 studies in Rhinitis, Allergic, PerennialNCT01134705, NCT01133626
- Feb 28, 2011Phase 3 study in Rhinitis, Allergic, SeasonalNCT01307319 · 715 enrolled · United States
- Jan 31, 2013Phase 3 study in Rhinitis, AllergicNCT01783548 · 547 enrolled · United States
- Jan 7, 20143 phase 3 studies in AsthmaNCT02031640, NCT02040779, NCT02040766
TargetBeta
“Glucocorticoid receptor agonist”ChEMBL 37, by rule
Other programs on NR3C1
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Dexamethasonerule | AbbVie | phase 4 | 174 |
| Budesoniderule | AstraZeneca | phase 4 | 167 |
| fluticasone furoaterule | GlaxoSmithKline | phase 4 | 97 |
| Prednisonerule | Johnson & Johnson | phase 4 | 65 |
| Prednisolonerule | Sanofi | phase 4 | 34 |
| betamethasone dipropionaterule | LEO Pharma | phase 4 | 27 |
| Methylprednisolonerule | Pfizer | phase 4 | 23 |
| dexamethasone phosphaterule | eyegate-pharmaceuticals-inc | phase 4 | 21 |
| Betamethasonerule | LEO Pharma | phase 4 | 9 |
| Triamcinolonerule | research-insight-llc | phase 4 | 5 |
| relacorilantrule | Corcept Therapeutics | phase 3 | 22 |
| Triamcinolone Acetoniderule | clearside-biomedical-inc | phase 3 | 20 |
Studies
All 14 Teva Pharmaceutical Industries leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02040779Asthma · United States | 3 | Completed | Dec 24, 2014 | 273 |
| NCT02040766Asthma · United States, Croatia, Mexico and more | 3 | Completed | Feb 2016 | 628 |
| NCT02031640Asthma · United States, Germany, Hungary and more | 3 | Completed | Nov 2014 | 1,113 |
| NCT01783548Rhinitis, Allergic · United States | 3 | Completed | Oct 2013 | 547 |
| NCT01307319Rhinitis, Allergic, Seasonal · United States | 3 | Completed | Jul 2011 | 715 |
| NCT01134705Rhinitis, Allergic, Perennial · United States | 3 | Completed | Oct 2010 | 474 |
| NCT01133626Rhinitis, Allergic, Perennial · United States | 3 | Completed | Sep 2010 | 107 |
| NCT01024608Rhinitis, Allergic, Seasonal · United States | 3 | Completed | Feb 28, 2010 | 340 |
| NCT00988247Rhinitis, Allergic, Perennial · United States | 3 | Completed | Feb 28, 2011 | 529 |
| NCT00854360Rhinitis, Allergic, Seasonal · United States | 2 | Completed | May 2009 | 487 |
| NCT00250341Asthma · United States | 4 | Completed | Sep 30, 2007 | 34 |
| NCT00109668Asthma · United States, Puerto Rico | 3 | Completed | Sep 30, 2006 | 415 |
| NCT00094016Asthma · United States, Puerto Rico | 3 | Completed | Jun 30, 2006 | 440 |
| NCT00071552Asthma · United States | 4 | Terminated | Jul 31, 2006 | 49 |
How it is read
Names in the registry
- “Beclomethasone dipropionate”, 6 entries
- “Beclometasone/Formoterol/Glycopyrrolate”, 2 entries
- “beclomethasone”, 2 entries
- “beclomethasone dipropionate plus formoterol fumarate combination”, 2 entries
- “Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium”, 2 entries
Conditions, from the studies’ own filings
- Asthma, 25 studies
- Pulmonary Disease, Chronic Obstructive, 7 studies
- Rhinitis, Allergic, Seasonal, 3 studies
- Rhinitis, Allergic, Perennial, 3 studies
- Graft vs Host Disease, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.